Xtremepicks Reports on EKO International (EKNL): Why Is EKNL a $1.25 Stock

Belize City, Belize -- (SBWIRE) -- 10/11/2012 -- Publishers of daily penny stock newsletter xtremepicks (http://www.xtremepicks.com) looks at EKO International (EKNL:Pinksheets)

EKNL definitely showed investors its strength today holding solid at key support levels and getting ready for the next monster breakout.

EKNL will be the biggest winner of 2012 hands down with $1.25 price target in sight

Is it because EKNL released monster news last week announcing “EKO with Dr. Ziemer’s NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.”?

Maybe it’s Dr. Paul Ziemer, world renowned for his expertise in the medical field joining the team at EKNL?

Well then, it has to be the first of many Clinics starting to treat patients with their FDA approved FREMS technology that will also be presented at the 13th annual Medical show in London this month.

Not to mention Dr. Ziemer teaming up with Dr. Snow of Neurometrix, a NASDAQ Listed company (NURO) for exclusive hands on demonstration of their testing unit?

No doubt, these are MONSTER updates that are turning a lot of heads, and institutional investors eying that $1.25 target level.

These updates already give EKNL HUGE valuation and potential…

…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY

When ever xtremepicks see opportunities like today to scoop super cheap shares on any minor dips, they take advantage of them and they definitely did again today – the potential is too big to pass up.

With a float of only 8 Million shares and insiders not selling a single share for less than dollar land, share inventory continues to dry up super quick making EKNL prices to move fast and furious towards record levels.

About EKO International
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.

About NeuroVasc Clinical Inc
NeuroVasc Clinical Inc. has brought a solution to the North American market place. The patented technology called FREMS is an FDA and Health Canada approved device that uses a patented electrical frequency and duty cycle to stimulate blood vessel re-growth and tissue regeneration in tissue that has compromised nerve and blood vessel function. The patient is treated 10 times once daily for 40 minutes and the effects on the tissue will last up to 18 month depending on the overall health of the patient. Thus this treatment becomes part of the maintenance of the lower limb for the diabetic patient as they age and will be a key player in the prevention of painful neuropathy and the development of dangerous wounds.

About Xtremepicks.com:
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep informed of the latest movers. Xtremepicks.com penny stock newsletter is the trading connection and remember to always do research, use stop loss orders to protect, and book profits when in a position to do so. Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do own due diligence. Xtremepicks did not receive any compensation for the distribution of this press release. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.